About Me
Dr. Ilozumba is a post-doctoral fellow at Huntsman Cancer Institute as well as in the Department of Population Health Sciences at the University of Utah. She received her PhD in epidemiology from the University of Florida. The goal of Dr. Ilozumba’s research is to understand the molecular, genetic, behavioral, and environmental risk factors of cancer etiology and outcomes. Dr. Mmadili has conducted several cancer research projects investigating the etiology of several cancer sites including breast, colorectal, and prostate cancer and their relationships with risk factors including genetic polymorphisms, obesity (adiposity), environmental exposures, dietary supplements, physical activity, energy intake, gene, and protein expression biomarkers of the mammalian target of rapamycin (mTOR) signaling pathway.
Dr. Ilozumba’s current research at HCI focuses on research projects within the Total Cancer Care Study, the MetaboCCC, the prospective FOCUS consortium, and the ColoCare study. She is investigating the associations of molecular, genetic, and environmental risk factors with colorectal cancer clinical outcomes, as well as the associations between the gut microbiome and onset of cachexia in colorectal cancer patients. Dr. Ilozumba is further applying omics in her research, in particular the interplay between microRNA expressions, body composition, and inflammatory biomarkers in relation to colorectal cancer clinical outcomes. Her research also involves addressing cancer health disparities in colorectal cancer patients from underserved and vulnerable populations including racial and ethnic minorities, rural population, and early-onset colorectal cancer patients.